Dr. Lal PathLabs Limited (LALPATHLAB.BO)
- Previous Close
2,772.80 - Open
2,700.75 - Bid 2,746.35 x --
- Ask 2,779.90 x --
- Day's Range
2,700.75 - 2,870.00 - 52 Week Range
2,210.00 - 3,645.00 - Volume
6,557 - Avg. Volume
11,576 - Market Cap (intraday)
231.563B - Beta (5Y Monthly) 0.20
- PE Ratio (TTM)
47.43 - EPS (TTM)
58.51 - Earnings Date Aug 5, 2025 - Aug 9, 2025
- Forward Dividend & Yield 30.00 (1.08%)
- Ex-Dividend Date Jun 5, 2025
- 1y Target Est
3,103.44
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.
www.lalpathlabs.comRecent News: LALPATHLAB.BO
View MorePerformance Overview: LALPATHLAB.BO
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LALPATHLAB.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LALPATHLAB.BO
View MoreValuation Measures
Market Cap
231.37B
Enterprise Value
220.79B
Trailing P/E
47.48
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.40
Price/Book (mrq)
10.64
Enterprise Value/Revenue
8.97
Enterprise Value/EBITDA
27.99
Financial Highlights
Profitability and Income Statement
Profit Margin
19.79%
Return on Assets (ttm)
13.38%
Return on Equity (ttm)
24.06%
Revenue (ttm)
24.61B
Net Income Avi to Common (ttm)
4.87B
Diluted EPS (ttm)
58.51
Balance Sheet and Cash Flow
Total Cash (mrq)
11.65B
Total Debt/Equity (mrq)
7.13%
Levered Free Cash Flow (ttm)
4.6B